Anmat participated in an international meeting on the Chikungunya vaccine

News Healthcare & Pharma General Updates

Date: 26th Mar, 2025 Source: National Administration of Drugs, Food and Medical Technology (ANMAT) Country: Argentina Original Source

Brief

On March 19-20, the National Administration of Medicamentos, Alimentos y Tecnología Médica (ANMAT) participated in an international meeting organized by CEPI and ANVISA in São Paulo, Brazil. This gathering brought together regulatory agencies worldwide and vaccine experts to discuss Chikungunya vaccine development, with Gabriela Bravo and Eliana Cela representing ANMAT on the panel of National Regulatory Authorities discussing protection correlates use. This meeting aimed to address scientific and regulatory advancements for safe and equitable access to the vaccine.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Administration of Drugs, Food and Medical Technology (ANMAT)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Anmat participated in an international meeting on the Chikungunya vaccine

Brief

National Administration of Drugs, Food and Medical Technology (ANMAT)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Anmat participated in an international meeting on the Chikungunya vaccine

Brief

National Administration of Drugs, Food and Medical Technology (ANMAT)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.